CG Oncology Inc. CGON 深 滬
交易中 12-22 09:45:16 美东时间
39.00
-0.030
-0.08%
華盛通- 最 高39.00
- 今 開39.00
- 成交量 3930股
- 最 低 39.00
- 昨 收 39.03
- 總市值 31.46亿
- 52周最高 46.01
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 14.80
- 委 比 0.00%
- 總股本 8066.62万
- 歷史最高 50.23
- 量 比 1.20
- 振 幅 0.00%
- 歷史最低 14.80
- 每 手 1
- 風險率 7.01%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 绩后分化！甲骨文遭14家大行集体下调目标价；新思科技、Planet获多家机构上调目标价！
今日重点评级关注：HC Wainwright & Co.：维持Moleculin Biotech"买入"评级，目标价从4美元升至22美元；HC Wainwright & Co.：上调Soluna Holdings评级至"买入"，目标价5美元
12-12 10:24
CG Oncology To Present Topline Data From BOND-003 Cohort P And First Results From CORE-008 Cohort A As Late-Breaking Abstracts At SUO 26th Annual Meeting
Cretostimogene demonstrated HG-EFS at 3- 6- and 9-months of 95.7%, 84.6% and 80.4%, respectively, in HR BCG UR Ta/T1 Disease in BOND-003 Cohort P CORE-008 Cohort A Data in HR BCG-Naïve NMIBC demonstrates 88% CR and
12-05 21:39
美股大行评级 | 摩根大通上调百度至"超配"，目标价升至188美元！Navan获多家机构首予"买入"评级，目标价最高30美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从4美元升至9美元；BTIG：维持Cullinan Therapeutics"买入"评级，目标价从32美元升至38美元
11-25 10:27
Truist Securities Initiates Coverage On CG Oncology with Buy Rating, Announces Price Target of $62
Truist Securities analyst Gregory Renza initiates coverage on CG Oncology (NASDAQ:CGON) with a Buy rating and announces Price Target of $62.
11-25 01:55
美股大行评级 | Stifel上调特斯拉目标价升至508美元；多家大行上调Vita Coco目标价最高至58美元
今日重点评级关注：HC Wainwright & Co.：维持Oncolytics Biotech"买入"评级，目标价从5美元升至10美元；HC Wainwright & Co.：维持Barinthus Biotherapeutics"买入"评级，目标价从3美元升至4美元
11-18 15:28
CG Oncology Q3 EPS $(0.57) Misses $(0.56) Estimate, Sales $1.666M Beat $65.300K Estimate
CG Oncology (NASDAQ:CGON) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.56) by 1.24 percent. This is a 90 percent decrease over losses of $(0.30) per share from the
11-15 05:54
ClearBridge SMID Cap Growth Strategy
The ClearBridge SMID Cap Growth Strategy underperformed its Russell 2500 Growth Index benchmark during the third quarter, with the index gaining 10.7%. As such, the performance of SMID growth equitie...
10-13 23:15
古根海姆证券给予CG Oncology“买入”评级
癌症治疗公司CG Oncology（CGON）股价大涨9.1%，此前古根海姆证券以“买入”评级开始覆盖该股，其目标价预示巨大上涨空间。该投行表示看好CG公司...
10-09 03:25
CG Oncology shares are trading higher after Guggenheim initiated coverage on the stock with a Buy rating and announced a $90 price target.
CG Oncology shares are trading higher after Guggenheim initiated coverage on th...
10-08 23:18
